Epidemiologic study on the origin of cancer after kidney transplantation

Transplantation

Volumn 77, Issue 3, 2004, Pages 426-428

  Pedotti, Paola ^a   Poli, Francesca ^a   Longhi, Elena ^a   Frison, Sara ^a   Caldara, Rossana ^b   Chiaramonte, Stefano ^c   Gotti, Eliana ^d   Marchini, Francesco ^e   Maresca, Cristina ^f   Sandrini, Silvio ^g   Scalamogna, Mario ^a   Taioli, Emanuela ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c Hospital San Bortolo   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e Padova Hospital   (Italy)

^f CA FONCELLO HOSPITAL   (Italy)

^g SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN;

ADULT; AGED; ARTICLE; CANCER; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE TRANSMISSION; DNA ISOLATION; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SHORT TANDEM REPEAT; TUMOR BIOPSY;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ORGAN TRANSPLANTATION; TANDEM REPEAT SEQUENCES; TISSUE DONORS;

EID: 10744220508     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000111757.08499.C2     Document Type: Article

References (22)

1. Montagnino G, Lorca E, Tarantino A, et al. Cancer incidence in 854 kidney transplant recipients from a single institution: Comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10: 461-469.
2. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. In: Cecka JM, Terasaki PI, eds. Clinical transplants. Los Angeles, UCLA Tissue Typing Laboratory 1998, pp 147-158.
3. Penn I. Donor transmitted disease: Cancer. Transplant Proc 1991; 23: 2629-2631.
4. Penn I. Transmission of cancer from organ donors. Ann Transplant 1997; 2: 7-12.
5. Myron Kauffman H, McBride MA, Cherikh WS, et al. Transplant tumor registry: Donor related malignancies. Transplantation 2002; 74: 358-362.
6. Donovan JA, Simmons FA, Esrason KT, et al. Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation 1997; 63: 80-84.
7. Loh E, Couch FJ, Hendricksen C, et al. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA 1997; 277: 133-137.
8. Schmitt C, Cire K, Schattenkirchner S, et al. Highly sensitive DNA typing for detecting tumors transmitted by transplantation. Transpl Int 1998; 11: 382-386.
9. Bodo I, Peters M, Radich JP, et al. Donor-derived acute promyelocytic leukemia in a liver-transplant recipient. N Engl J Med 1999; 341: 807-813.
10. Stephens JK, Everson GT, Elliott CL, et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 2000; 70: 232-236.
11. Baehner R, Magrane G, Balassanian R, et al. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Hum Pathol 2000; 31: 1425-1429.
12. Ng IO, Shek TW, Thung SN, et al. Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin. Mod Pathol 2000; 13: 1180-1185.
13. Roza AM, Johnson C, Juckett M, et al. Adenocarcinoma arising in a transplanted pancreas. Transplantation 2001; 72: 1156-1157.
14. Baron PW, Heneghan MA, Suhocki PV, et al. Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation. Liver Transpl 2001; 7: 62-67.
15. Kakar S, Burgart LJ, Charlton MR, et al. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol 2002; 33: 435-436.
16. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ, et al., eds. PCR protocols. San Diego, Academic Press 1990, pp 153-158.
17. Sullivan KM, Pope S, Gill P, et al. Automated DNA profiling by fluorescent labeling of PCR products. PCR Methods Appl 1992; 2: 34-40.
18. Pindolia K, Janakiraman N, Kasten-Sportes C, et al. Enhanced assessment of allogenic bone marrow transplant engraftment using automated fluorescent-based typing. Bone Marrow Transplant 1999; 24: 1235-1241.
19. Thiede C, Florek M, Bornhäuser M, et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055-1060.
20. Millson AS, Spangler FL, Wittwer CT, et al. Comparison of automated short tandem repeat and manual variable number of tandem repeat analysis of chimerism in bone marrow transplant patients. Diagn Mol Pathol 2000; 9: 91-97.
21. Nuckols JD, Rasheed BK, McGlennen RC, et al. Evaluation of an automated technique for assessment of marrow engraftment after allogenic bone marrow transplantation using a commercially available kit. Am J Clin Pathol 2000; 113: 135-140.
22. Sells RA. Iatrogenic problems caused by immunosuppressive drugs in transplant recipients. Transplant Proc 1998; 30: 14S-19S.